[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Outcomes Following LVAD Implantation in Patients with Cancer: A Nationwide Analysis of Readmissions, Mortality, and Resource Utilization",
    "section": "",
    "text": "Reference Studies:\n\nAgrawal et al., 2018\n\nStudy Objective:\nTo identify patient- and hospital-level predictors of 30-day all-cause hospital readmission among adults patients with/without cancer undergoing LVAD implantation using a nationally representative dataset. This study also evaluates the clinical and economic burden of readmission in this high-risk population, including its association with in-hospital mortality.\nData Source:\nA retrospective cohort study using the 2016–2017 Nationwide Readmissions Database (NRD), developed by the Healthcare Cost and Utilization Project (HCUP). The NRD enables tracking of individual patients across hospitalizations within a given year via synthetic identifiers, capturing discharges from U.S. community hospitals and supporting survey-weighted national estimates through complex sampling design.\nCohort Definition:\nInclusion criteria:\n\nPatients aged &gt;= 18 years\nPatients who underwent LVAD implantation (ICD-10 PCS: 02HA0QZ)\nIndex discharge by the end of November to allow for a complete 30-day follow-up period\nComplete data on LOS and NRD_DAYSTOEVENT, required to compute discharge dates\n\nExclusion criteria:\n\nHeart transplant-related admissions\nPatients undergoing BiVAD implantation\nTrauma-related hospitalizations were excluded only from the readmission pool to avoid injury-related returns unrelated to the index LVAD hospitalization.\n\nExposure:\n\nThe primary exposure was cancer (ICD 10 CM: C00-C96)\n\nWith Cancer\nWithout Cancer\n\n\nCancer status was assessed only during the index hospitalization, not during readmissions.\nOutcomes:\n\nPrimary outcomes:\n\n30-day all-cause readmission\n\nSecondary outcomes:\n\nIn-hospital mortality during the index hospitalization\nLength of stay (LOS), measured in days\nInflation-adjusted total hospital charges, expressed in 2017 U.S. dollars\nNon-home discharge disposition (transfer, skilled nursing/intermediate facility, AMA, unknown destination, or in-hospital death)\nAcute kidney injury\nSepsis\nMajor bleed (Composite of GI bleed and intracranial hemorrhage)\n\nTop cardiovascular causes of readmission\n\nCovariates:\n\nDemographics: age, sex, primary expected payer and median household income quartile by ZIP code.\nClinical characteristics: Elixhauser comorbidity index, length of stay, non-home discharge.\nHospital characteristics: hospital bed size, and hospital location/teaching.\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAll analyses incorporated NRD’s complex sampling design via the survey and srvyr packages.\n\nDescriptive Statistics:\n\nWeighted baseline characteristics of index hospitalizations were summarized and stratified by cancer status to compare those with vs without cancer.\nP-values from statistical tests (Rao–Scott adjusted chi-square for categorical variables; Kruskal–Wallis test for continuous variables).\n\nMultivariable Regression:\n\nA survey-weighted logistic regression modeled predictors of 30-day readmission.\nThe model included demographic, clinical, hospital-level, and index-stay factors.\nResults were exponentiated to yield odds ratios (ORs) with 95% confidence intervals.\n\n\nSoftware: All analyses were conducted in R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Outcomes Following LVAD Implantation in Patients with Cancer: A Nationwide Analysis of Readmissions, Mortality, and Resource Utilization",
    "section": "",
    "text": "Reference Studies:\n\nAgrawal et al., 2018\n\nStudy Objective:\nTo identify patient- and hospital-level predictors of 30-day all-cause hospital readmission among adults patients with/without cancer undergoing LVAD implantation using a nationally representative dataset. This study also evaluates the clinical and economic burden of readmission in this high-risk population, including its association with in-hospital mortality.\nData Source:\nA retrospective cohort study using the 2016–2017 Nationwide Readmissions Database (NRD), developed by the Healthcare Cost and Utilization Project (HCUP). The NRD enables tracking of individual patients across hospitalizations within a given year via synthetic identifiers, capturing discharges from U.S. community hospitals and supporting survey-weighted national estimates through complex sampling design.\nCohort Definition:\nInclusion criteria:\n\nPatients aged &gt;= 18 years\nPatients who underwent LVAD implantation (ICD-10 PCS: 02HA0QZ)\nIndex discharge by the end of November to allow for a complete 30-day follow-up period\nComplete data on LOS and NRD_DAYSTOEVENT, required to compute discharge dates\n\nExclusion criteria:\n\nHeart transplant-related admissions\nPatients undergoing BiVAD implantation\nTrauma-related hospitalizations were excluded only from the readmission pool to avoid injury-related returns unrelated to the index LVAD hospitalization.\n\nExposure:\n\nThe primary exposure was cancer (ICD 10 CM: C00-C96)\n\nWith Cancer\nWithout Cancer\n\n\nCancer status was assessed only during the index hospitalization, not during readmissions.\nOutcomes:\n\nPrimary outcomes:\n\n30-day all-cause readmission\n\nSecondary outcomes:\n\nIn-hospital mortality during the index hospitalization\nLength of stay (LOS), measured in days\nInflation-adjusted total hospital charges, expressed in 2017 U.S. dollars\nNon-home discharge disposition (transfer, skilled nursing/intermediate facility, AMA, unknown destination, or in-hospital death)\nAcute kidney injury\nSepsis\nMajor bleed (Composite of GI bleed and intracranial hemorrhage)\n\nTop cardiovascular causes of readmission\n\nCovariates:\n\nDemographics: age, sex, primary expected payer and median household income quartile by ZIP code.\nClinical characteristics: Elixhauser comorbidity index, length of stay, non-home discharge.\nHospital characteristics: hospital bed size, and hospital location/teaching.\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAll analyses incorporated NRD’s complex sampling design via the survey and srvyr packages.\n\nDescriptive Statistics:\n\nWeighted baseline characteristics of index hospitalizations were summarized and stratified by cancer status to compare those with vs without cancer.\nP-values from statistical tests (Rao–Scott adjusted chi-square for categorical variables; Kruskal–Wallis test for continuous variables).\n\nMultivariable Regression:\n\nA survey-weighted logistic regression modeled predictors of 30-day readmission.\nThe model included demographic, clinical, hospital-level, and index-stay factors.\nResults were exponentiated to yield odds ratios (ORs) with 95% confidence intervals.\n\n\nSoftware: All analyses were conducted in R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#descriptive-analyses",
    "href": "quarto/index.html#descriptive-analyses",
    "title": "Outcomes Following LVAD Implantation in Patients with Cancer: A Nationwide Analysis of Readmissions, Mortality, and Resource Utilization",
    "section": "Descriptive Analyses",
    "text": "Descriptive Analyses\n\nBaseline Characteristics\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 8,0871\nWithout Cancer\nN = 7,6371\nWith Cancer\nN = 4511\np-value2\n\n\n\n\nAge (years)\n56 (13)\n56 (13)\n58 (13)\n0.13\n\n\nSex\n\n\n\n\n\n\n0.12\n\n\n    Male\n6,206 (77%)\n5,881 (77%)\n325 (72%)\n\n\n\n\n    Female\n1,881 (23%)\n1,756 (23%)\n125 (28%)\n\n\n\n\nInsurance\n\n\n\n\n\n\n0.2\n\n\n    Private\n2,762 (34%)\n2,616 (34%)\n146 (33%)\n\n\n\n\n    Medicaid\n933 (12%)\n896 (12%)\n37 (8.2%)\n\n\n\n\n    Medicare\n4,023 (50%)\n3,772 (50%)\n251 (56%)\n\n\n\n\n    Other\n318 (4.0%)\n303 (4.0%)\n15 (3.3%)\n\n\n\n\nMedian Income Quartile\n\n\n\n\n\n\n0.8\n\n\n    0-25th percentile\n2,255 (28%)\n2,123 (28%)\n132 (29%)\n\n\n\n\n    26th to 50th percentile\n2,261 (28%)\n2,135 (28%)\n126 (28%)\n\n\n\n\n    51st to 75th percentile\n1,970 (25%)\n1,871 (25%)\n99 (22%)\n\n\n\n\n    76th to 100th percentile\n1,516 (19%)\n1,424 (19%)\n92 (21%)\n\n\n\n\nHospital Bed Size\n\n\n\n\n\n\n0.5\n\n\n    Small\n163 (2.0%)\n163 (2.1%)\n0 (0%)\n\n\n\n\n    Large\n7,269 (90%)\n6,844 (90%)\n425 (94%)\n\n\n\n\n    Medium\n655 (8.1%)\n629 (8.2%)\n26 (5.7%)\n\n\n\n\nHospital Teaching Status\n\n\n\n\n\n\n0.2\n\n\n    Metropolitan, non-teaching\n250 (3.1%)\n244 (3.2%)\n6 (1.4%)\n\n\n\n\n    Metropolitan, teaching\n7,837 (97%)\n7,393 (97%)\n444 (99%)\n\n\n\n\nElixhauser's Comorbidity Index\n7.47 (2.37)\n7.44 (2.39)\n8.05 (2.08)\n0.003\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment\n\n\n\n\n\n\n\n\n\n\nOutcomes of Index Hospitalizations\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 8,0871\nWithout Cancer\nN = 7,6371\nWith Cancer\nN = 4511\np-value2\n\n\n\n\n30-Day Readmission\n1,230 (15%)\n1,171 (15%)\n60 (13%)\n0.4\n\n\nIn-Hospital Mortality\n873 (11%)\n802 (10%)\n71 (16%)\n0.090\n\n\nLength of Stay (days)\n30 (20, 46)\n30 (20, 45)\n39 (28, 61)\n&lt;0.001\n\n\nInflation-Adjusted Total Charges ($)\n774,182 (568,518, 1,130,723)\n767,108 (563,602, 1,123,244)\n935,208 (662,498, 1,401,666)\n&lt;0.001\n\n\nNon Home Discharge\n1,882 (23%)\n1,758 (23%)\n123 (27%)\n0.2\n\n\nAcute kidney injury\n5,358 (66%)\n4,998 (65%)\n360 (80%)\n&lt;0.001\n\n\nSepsis\n1,142 (14%)\n1,028 (13%)\n114 (25%)\n&lt;0.001\n\n\nMajor bleed\n916 (11%)\n814 (11%)\n101 (22%)\n&lt;0.001\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Outcomes Following LVAD Implantation in Patients with Cancer: A Nationwide Analysis of Readmissions, Mortality, and Resource Utilization",
    "section": "Multivariable Logistic Regression",
    "text": "Multivariable Logistic Regression\n\nPredictors of 30-Day Readmission\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nCancer\n\n\n\n\n\n\n\n\n    Without Cancer\n—\n—\n\n\n\n\n    With Cancer\n0.81\n0.55, 1.19\n0.3\n\n\nAge (years)\n1.01\n1.00, 1.02\n0.044\n\n\nSex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n1.20\n0.94, 1.53\n0.14\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.02\n0.73, 1.41\n&gt;0.9\n\n\n    Medicare\n1.29\n1.03, 1.61\n0.027\n\n\n    Other\n0.91\n0.57, 1.47\n0.7\n\n\nMedian Income Quartile\n\n\n\n\n\n\n\n\n    0-25th percentile\n—\n—\n\n\n\n\n    26th to 50th percentile\n1.02\n0.73, 1.44\n0.9\n\n\n    51st to 75th percentile\n1.15\n0.90, 1.48\n0.3\n\n\n    76th to 100th percentile\n1.18\n0.85, 1.64\n0.3\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Small\n—\n—\n\n\n\n\n    Large\n1.24\n0.56, 2.75\n0.6\n\n\n    Medium\n0.98\n0.38, 2.49\n&gt;0.9\n\n\nHospital Teaching Status\n\n\n\n\n\n\n\n\n    Metropolitan, non-teaching\n—\n—\n\n\n\n\n    Metropolitan, teaching\n0.83\n0.38, 1.78\n0.6\n\n\nElixhauser's Comorbidity Index\n0.97\n0.91, 1.04\n0.4\n\n\nLength of Stay (days)\n1.00\n1.00, 1.01\n0.010\n\n\nNon Home Discharge\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.55\n0.42, 0.72\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nAcute kidney injury:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nCancer\n\n\n\n\n\n\n\n\n    Without Cancer\n—\n—\n\n\n\n\n    With Cancer\n1.54\n1.04, 2.28\n0.033\n\n\nAge (years)\n0.99\n0.98, 1.00\n0.020\n\n\nSex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n0.63\n0.50, 0.79\n&lt;0.001\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.92\n0.70, 1.22\n0.6\n\n\n    Medicare\n1.01\n0.81, 1.27\n0.9\n\n\n    Other\n1.12\n0.71, 1.75\n0.6\n\n\nMedian Income Quartile\n\n\n\n\n\n\n\n\n    0-25th percentile\n—\n—\n\n\n\n\n    26th to 50th percentile\n1.09\n0.89, 1.33\n0.4\n\n\n    51st to 75th percentile\n0.97\n0.78, 1.22\n0.8\n\n\n    76th to 100th percentile\n1.27\n0.95, 1.71\n0.11\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Small\n—\n—\n\n\n\n\n    Large\n3.29\n1.09, 9.89\n0.034\n\n\n    Medium\n2.60\n0.82, 8.20\n0.10\n\n\nHospital Teaching Status\n\n\n\n\n\n\n\n\n    Metropolitan, non-teaching\n—\n—\n\n\n\n\n    Metropolitan, teaching\n0.93\n0.42, 2.06\n0.8\n\n\nElixhauser's Comorbidity Index\n1.26\n1.17, 1.35\n&lt;0.001\n\n\nLength of Stay (days)\n1.02\n1.01, 1.03\n&lt;0.001\n\n\nNon Home Discharge\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.77\n2.23, 3.44\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nSepsis:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nCancer\n\n\n\n\n\n\n\n\n    Without Cancer\n—\n—\n\n\n\n\n    With Cancer\n1.71\n1.19, 2.45\n0.004\n\n\nAge (years)\n0.99\n0.98, 1.00\n0.011\n\n\nSex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n0.80\n0.64, 0.99\n0.043\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.80\n0.53, 1.19\n0.3\n\n\n    Medicare\n0.97\n0.76, 1.26\n0.8\n\n\n    Other\n1.33\n0.74, 2.39\n0.3\n\n\nMedian Income Quartile\n\n\n\n\n\n\n\n\n    0-25th percentile\n—\n—\n\n\n\n\n    26th to 50th percentile\n0.93\n0.73, 1.19\n0.6\n\n\n    51st to 75th percentile\n0.97\n0.70, 1.34\n0.8\n\n\n    76th to 100th percentile\n1.00\n0.73, 1.38\n&gt;0.9\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Small\n—\n—\n\n\n\n\n    Large\n2.66\n0.72, 9.83\n0.14\n\n\n    Medium\n2.17\n0.56, 8.42\n0.3\n\n\nHospital Teaching Status\n\n\n\n\n\n\n\n\n    Metropolitan, non-teaching\n—\n—\n\n\n\n\n    Metropolitan, teaching\n1.09\n0.62, 1.94\n0.8\n\n\nElixhauser's Comorbidity Index\n1.04\n0.99, 1.10\n0.14\n\n\nLength of Stay (days)\n1.02\n1.02, 1.03\n&lt;0.001\n\n\nNon Home Discharge\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n4.24\n3.19, 5.63\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nMajor Bleed\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nCancer\n\n\n\n\n\n\n\n\n    Without Cancer\n—\n—\n\n\n\n\n    With Cancer\n2.00\n1.46, 2.73\n&lt;0.001\n\n\nAge (years)\n1.02\n1.01, 1.03\n0.002\n\n\nSex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n0.98\n0.77, 1.25\n0.9\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.24\n0.83, 1.86\n0.3\n\n\n    Medicare\n0.94\n0.68, 1.30\n0.7\n\n\n    Other\n1.14\n0.53, 2.46\n0.7\n\n\nMedian Income Quartile\n\n\n\n\n\n\n\n\n    0-25th percentile\n—\n—\n\n\n\n\n    26th to 50th percentile\n1.11\n0.76, 1.61\n0.6\n\n\n    51st to 75th percentile\n0.89\n0.60, 1.31\n0.5\n\n\n    76th to 100th percentile\n1.01\n0.68, 1.50\n&gt;0.9\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Small\n—\n—\n\n\n\n\n    Large\n0.84\n0.27, 2.61\n0.8\n\n\n    Medium\n0.76\n0.21, 2.77\n0.7\n\n\nHospital Teaching Status\n\n\n\n\n\n\n\n\n    Metropolitan, non-teaching\n—\n—\n\n\n\n\n    Metropolitan, teaching\n2.13\n0.81, 5.57\n0.12\n\n\nElixhauser's Comorbidity Index\n1.10\n1.05, 1.17\n&lt;0.001\n\n\nLength of Stay (days)\n1.02\n1.01, 1.02\n&lt;0.001\n\n\nNon Home Discharge\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.13\n1.58, 2.87\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Outcomes Following LVAD Implantation in Patients with Cancer: A Nationwide Analysis of Readmissions, Mortality, and Resource Utilization",
    "section": "Multivariable Linear Regression",
    "text": "Multivariable Linear Regression\n\nLength of Stay\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nexp(Beta)\n95% CI\np-value\n\n\n\n\nCancer\n\n\n\n\n\n\n\n\n    Without Cancer\n—\n—\n\n\n\n\n    With Cancer\n5,274\n67.9, 409,867\n&lt;0.001\n\n\nAge (years)\n0.92\n0.84, 1.01\n0.086\n\n\nSex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n17.5\n1.58, 193\n0.020\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.14\n0.00, 6.91\n0.3\n\n\n    Medicare\n0.15\n0.01, 1.62\n0.12\n\n\n    Other\n0.20\n0.00, 225\n0.7\n\n\nMedian Income Quartile\n\n\n\n\n\n\n\n\n    0-25th percentile\n—\n—\n\n\n\n\n    26th to 50th percentile\n0.08\n0.01, 1.05\n0.054\n\n\n    51st to 75th percentile\n0.03\n0.00, 0.42\n0.010\n\n\n    76th to 100th percentile\n0.26\n0.01, 8.47\n0.4\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Small\n—\n—\n\n\n\n\n    Large\n26.7\n0.00, 1,287,300,692\n0.7\n\n\n    Medium\n18.7\n0.00, 1,433,894,441\n0.8\n\n\nHospital Teaching Status\n\n\n\n\n\n\n\n\n    Metropolitan, non-teaching\n—\n—\n\n\n\n\n    Metropolitan, teaching\n17,567\n0.72, 429,374,367\n0.058\n\n\nElixhauser's Comorbidity Index\n4.55\n3.09, 6.70\n&lt;0.001\n\n\nNon Home Discharge\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3,633,167\n121,549, 108,597,139\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation-adjusted Total Charge\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nexp(Beta)\n95% CI\np-value\n\n\n\n\nCancer\n\n\n\n\n\n\n\n\n    Without Cancer\n—\n—\n\n\n\n\n    With Cancer\nInf\n0.00, Inf\n0.2\n\n\nAge (years)\nInf\n0.00, Inf\n0.6\n\n\nSex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n0.00\n0.00, Inf\n0.6\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\nInf\n0.00, Inf\n0.3\n\n\n    Medicare\n0.00\n0.00, Inf\n0.092\n\n\n    Other\n0.00\n0.00, Inf\n0.4\n\n\nMedian Income Quartile\n\n\n\n\n\n\n\n\n    0-25th percentile\n—\n—\n\n\n\n\n    26th to 50th percentile\nInf\n0.00, Inf\n0.3\n\n\n    51st to 75th percentile\nInf\n0.00, Inf\n0.13\n\n\n    76th to 100th percentile\nInf\n0.00, Inf\n0.13\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Small\n—\n—\n\n\n\n\n    Large\nInf\nInf, Inf\n0.008\n\n\n    Medium\nInf\nInf, Inf\n0.012\n\n\nHospital Teaching Status\n\n\n\n\n\n\n\n\n    Metropolitan, non-teaching\n—\n—\n\n\n\n\n    Metropolitan, teaching\nInf\n0.00, Inf\n0.5\n\n\nElixhauser's Comorbidity Index\n0.00\n0.00, Inf\n0.2\n\n\nLength of Stay (days)\nInf\nInf, Inf\n&lt;0.001\n\n\nNon Home Discharge\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\nInf\nInf, Inf\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval"
  },
  {
    "objectID": "quarto/index.html#top-cardiovascular-causes-of-readmission",
    "href": "quarto/index.html#top-cardiovascular-causes-of-readmission",
    "title": "Outcomes Following LVAD Implantation in Patients with Cancer: A Nationwide Analysis of Readmissions, Mortality, and Resource Utilization",
    "section": "Top Cardiovascular Causes of Readmission",
    "text": "Top Cardiovascular Causes of Readmission\n\n\n\n\n\n\n\n\n\nDiagnosis code\nName\nCount\nProportion\n\n\n\n\nI50\nHeart failure\n95.160\n0.077305643\n\n\nI47\nParoxysmal tachycardia\n85.706\n0.069625446\n\n\nI13\nHypertensive heart and chronic kidney disease\n53.439\n0.043412529\n\n\nI11\nHypertensive heart disease\n31.878\n0.025896903\n\n\nI25\nChronic ischemic heart disease\n17.771\n0.014436723\n\n\nI63\nCerebral infarction\n13.542\n0.011001188\n\n\nI95\nHypotension\n11.845\n0.009622587\n\n\nI10\nEssential hypertension\n11.051\n0.008977561"
  }
]